_version_ 1783714892983828480
author Gritti, Giuseppe
Raimondi, Federico
Bottazzi, Barbara
Ripamonti, Diego
Riva, Ivano
Landi, Francesco
Alborghetti, Leonardo
Frigeni, Marco
Damiani, Marianna
Micò, Caterina
Fagiuoli, Stefano
Lorini, Ferdinando Luca
Gandini, Lucia
Novelli, Luca
Morgan, Jonathan P.
Owens, Benjamin M. J.
Kanhai, Karan J. K.
Reljanovic, Gordana Tonkovic
Rizzi, Marco
Di Marco, Fabiano
Mantovani, Alberto
Rambaldi, Alessandro
author_facet Gritti, Giuseppe
Raimondi, Federico
Bottazzi, Barbara
Ripamonti, Diego
Riva, Ivano
Landi, Francesco
Alborghetti, Leonardo
Frigeni, Marco
Damiani, Marianna
Micò, Caterina
Fagiuoli, Stefano
Lorini, Ferdinando Luca
Gandini, Lucia
Novelli, Luca
Morgan, Jonathan P.
Owens, Benjamin M. J.
Kanhai, Karan J. K.
Reljanovic, Gordana Tonkovic
Rizzi, Marco
Di Marco, Fabiano
Mantovani, Alberto
Rambaldi, Alessandro
author_sort Gritti, Giuseppe
collection PubMed
description
format Online
Article
Text
id pubmed-8238381
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82383812021-06-29 Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 Gritti, Giuseppe Raimondi, Federico Bottazzi, Barbara Ripamonti, Diego Riva, Ivano Landi, Francesco Alborghetti, Leonardo Frigeni, Marco Damiani, Marianna Micò, Caterina Fagiuoli, Stefano Lorini, Ferdinando Luca Gandini, Lucia Novelli, Luca Morgan, Jonathan P. Owens, Benjamin M. J. Kanhai, Karan J. K. Reljanovic, Gordana Tonkovic Rizzi, Marco Di Marco, Fabiano Mantovani, Alberto Rambaldi, Alessandro Leukemia Correction Nature Publishing Group UK 2021-06-28 2021 /pmc/articles/PMC8238381/ /pubmed/34183767 http://dx.doi.org/10.1038/s41375-021-01329-8 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correction
Gritti, Giuseppe
Raimondi, Federico
Bottazzi, Barbara
Ripamonti, Diego
Riva, Ivano
Landi, Francesco
Alborghetti, Leonardo
Frigeni, Marco
Damiani, Marianna
Micò, Caterina
Fagiuoli, Stefano
Lorini, Ferdinando Luca
Gandini, Lucia
Novelli, Luca
Morgan, Jonathan P.
Owens, Benjamin M. J.
Kanhai, Karan J. K.
Reljanovic, Gordana Tonkovic
Rizzi, Marco
Di Marco, Fabiano
Mantovani, Alberto
Rambaldi, Alessandro
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title_full Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title_fullStr Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title_full_unstemmed Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title_short Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
title_sort correction: siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe covid-19
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238381/
https://www.ncbi.nlm.nih.gov/pubmed/34183767
http://dx.doi.org/10.1038/s41375-021-01329-8
work_keys_str_mv AT grittigiuseppe correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT raimondifederico correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT bottazzibarbara correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT ripamontidiego correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT rivaivano correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT landifrancesco correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT alborghettileonardo correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT frigenimarco correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT damianimarianna correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT micocaterina correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT fagiuolistefano correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT loriniferdinandoluca correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT gandinilucia correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT novelliluca correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT morganjonathanp correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT owensbenjaminmj correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT kanhaikaranjk correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT reljanovicgordanatonkovic correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT rizzimarco correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT dimarcofabiano correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT mantovanialberto correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19
AT rambaldialessandro correctionsiltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19